Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
CPX-351 Appears Superior to 7+3 in Adverse-Risk AML and AML-MRC
HTML
Details
Locations
Year:
2022
Type:
conference-abstract
Source:
Blood
DOI:
10.1182/blood-2022-171129
Authors:
Ian M. Bouligny,
Graeme Murray,
Valerie Tran,
Juhi Gor,
Yiwei Hang,
Yanal Alnimer,
Kyle Zacholski,
Chad Venn,
Keri Maher
show all 9
Institutions:
Virginia Commonwealth University,
VCU Massey Comprehensive Cancer Center
Language:
English
Topic:
Acute Myeloid Leukemia Research
Subfield:
Hematology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W4310096385
Cites:
Cited by:
Related to:
10